MeMed, which has developed a medical diagnostics kit, has completed a financing totaling over $70 million from a group of Chinese and Israeli investors.
Read more on Haaretz here.
MeMed, which has developed a medical diagnostics kit, has completed a financing totaling over $70 million from a group of Chinese and Israeli investors.
Read more on Haaretz here.
![[BetterSeeds in Technology for You] BetterSeeds’ CRISPR-Based Technology: The Key to Agricultural Resilience and Sustainability](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
